Stay updated on Nivolumab in AML Remission at High Risk Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in AML Remission at High Risk Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page adds a recruitment status note and new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the heading formatting for Intervention/Treatment as well as the revision label to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-13T00:56:24.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a newer revision of the record. This appears to be a maintenance update to the page rather than a substantive change to the study content.
    Difference
    0.1%
    Check dated 2026-06-05T21:36:24.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Adds a new page revision tag v3.5.4 and removes v3.5.3, signaling a rebuild/update of the page's version rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-05-15T11:38:24.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Updates the displayed site revision/version indicator from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T06:29:08.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:47:27.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and deleted Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:33:23.000Z thumbnail image

Stay in the know with updates to Nivolumab in AML Remission at High Risk Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in AML Remission at High Risk Clinical Trial page.